bf/NASDAQ:TROW_icon.png

NASDAQ:TROW

T. Rowe Price Group, Inc.

  • Stock

USD

Last Close

117.89

27/03 20:00

Market Cap

24.60B

Beta: 1.31

Volume Today

1.34M

Avg: 1.62M

PE Ratio

15.09

PFCF: 25.41

Dividend Yield

4.49%

Payout:69.07%

  • industry

    Asset Management
  • exchange

    NASDAQ Global Select
  • website

    www.troweprice.com
  • ipo date

    Jan 04, 1986
  • full time employees

    7,868
  • currency

    USD

T. Rowe Price Group, Inc. is a publicly owned investment manager. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It launches and manages equity and fixed income mutual funds. The firm invests in the public equity ...Show More

Earnings

Earnings per Share (Estimate*)

0.511.522.533.52015-10-222017-10-262019-10-242021-10-282023-10-27

Revenue (Estimate*)

500M1B1.50B2B2.50B2015-10-222017-10-262019-10-242021-10-282023-10-27

*Estimate based on analyst consensus

founders

  • Thomas Price Jr.

num employees

  • 5001-10000

recent investments

Money RaisedFunding RoundLead InvestorAnnounced DateOrganization Name
$320MSeries C - Lambda15-02-2024Lambda
$254MSeries E - Freenome15-02-2024Freenome
$112MSeries B - ProfoundBio13-02-2024ProfoundBio
$145MSeries C - Lilac Solutions12-02-2024Lilac Solutions
$101MSeries C - Odyssey Therapeutics05-12-2023Odyssey Therapeutics
$105MVenture Round - RefleXion Medical15-11-2023RefleXion Medical
$10MVenture Round - ApitureYes14-11-2023Apiture
$40MConvertible Note - StashYes13-10-2023Stash
$273MSeries C - Generate Biomedicines15-09-2023Generate Biomedicines
$684.6MSeries I - DatabricksYes14-09-2023Databricks

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.